[HTML][HTML] N7-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis

H Han, C Yang, J Ma, S Zhang, S Zheng, R Ling… - Nature …, 2022 - nature.com
H Han, C Yang, J Ma, S Zhang, S Zheng, R Ling, K Sun, S Guo, B Huang, Y Liang, L Wang…
Nature Communications, 2022nature.com
Mis-regulated RNA modifications promote the processing and translation of oncogenic
mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear.
Here we reveal that tRNA m7G methyltransferase complex proteins METTL1 and WDR4 are
significantly up-regulated in esophageal squamous cell carcinoma (ESCC) tissues and
associated with poor ESCC prognosis. In addition, METTL1 and WDR4 promote ESCC
progression via the tRNA m7G methyltransferase activity in vitro and in vivo. Mechanistically …
Abstract
Mis-regulated RNA modifications promote the processing and translation of oncogenic mRNAs to facilitate cancer progression, while the molecular mechanisms remain unclear. Here we reveal that tRNA m7G methyltransferase complex proteins METTL1 and WDR4 are significantly up-regulated in esophageal squamous cell carcinoma (ESCC) tissues and associated with poor ESCC prognosis. In addition, METTL1 and WDR4 promote ESCC progression via the tRNA m7G methyltransferase activity in vitro and in vivo. Mechanistically, METTL1 or WDR4 knockdown leads to decreased expression of m7G-modified tRNAs and reduces the translation of a subset of oncogenic transcripts enriched in RPTOR/ULK1/autophagy pathway. Furthermore, ESCC models using Mettl1 conditional knockout and knockin mice uncover the essential function of METTL1 in promoting ESCC tumorigenesis in vivo. Our study demonstrates the important oncogenic function of mis-regulated tRNA m7G modification in ESCC, and suggest that targeting METTL1 and its downstream signaling axis could be a promising therapeutic target for ESCC treatment.
nature.com